Cullinan Oncology Inc (CGEM)

Finanzdaten der Cullinan Oncology Inc-Aktie (CGEM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	-0.44	-	-	-
Operating Expenses	1.52% 45.48	44.80	37.60	62.76	32.61
Benefits Costs and Expenses	2.43% 39.69	38.74	-	-	28.95
Costs And Expenses	1.52% 45.48	44.80	-	-	32.61
Operating Income/Loss	0.53% -45.48	-45.24	-37.60	-62.76	-32.61
Income/Loss From Continuing Operations Before Tax	1.28% -39.69	-39.18	-32.21	-58.14	-28.95
Income Tax Expense/Benefit	-14.12	-	-	-	-1.858
Income/Loss From Continuing Operations After Tax	34.76% -25.56	-39.18	-32.21	-58.14	-27.09
Net Income/Loss	34.76% -25.56	-39.18	-32.21	-58.14	-27.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-1.76	-	-	-0.179	-0.306
Basic Average Shares	99.02% 0.42	42.73	39.95	40.68	0.198
Diluted Average Shares	99.02% 0.42	42.73	39.95	40.68	0.06
Basic Earnings Per Share	40.66% -0.54	-0.91	-0.82	-1.42	-0.61
Diluted Earnings Per Share	40.66% -0.54	-0.91	-0.82	-1.42	-0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-